Recommendations for Development of Botanical Polyphenols as “Natural Drugs” for Promotion of Resilience Against Stress-Induced Depression and Cognitive Impairment

NeuroMolecular Medicine

Volumn 18, Issue 3, 2016, Pages 487-495

  Ward, Libby ^a   Pasinetti, Giulio Maria ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Botanicals; Microbiome; Polyphenols; Resilience; Sleep deprivation induced cognitive impairment; Stress induced depression

Indexed keywords

3' O METHYLEPICATECHIN 5 O GLUCURONIDE; FLAVAN 3 OL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPHENOL; PROANTHOCYANIDIN DERIVATIVE; UNCLASSIFIED DRUG; PLANT EXTRACT;

BIOACCUMULATION; COGNITIVE DEFECT; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG INFORMATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; HEALTH PROMOTION; HUMAN; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SLEEP DEPRIVATION; TREATMENT INDICATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; PSYCHOLOGICAL RESILIENCE;

COGNITIVE DYSFUNCTION; DEPRESSION; HUMANS; PLANT EXTRACTS; POLYPHENOLS; RESILIENCE, PSYCHOLOGICAL;

EID: 84976322978     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-016-8418-6     Document Type: Review

References (61)

1. Abd El Mohsen, M. M., Kuhnle, G., Rechner, A. R., Schroeter, H., Rose, S., Jenner, P., et al. (2002). Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology and Medicine, 33, 1693–1702.
2. Abd El-Mohsen, M., Bayele, H., Kuhnle, G., Gibson, G., Debnam, E., Kaila, S. S., et al. (2006). Distribution of [3H]trans-resveratrol in rat tissues following oral administration. British Journal of Nutrition, 96, 62–70.
3. Aburn, G., Gott, M., & Hoare, K. (2016). What is resilience? An integrative review of the empirical literature. Journal of Advanced Nursing, 72, 980–1000.
4. Association, A. P. (2013). Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing.
5. Aura, A. M., Mattila, I., Seppanen-Laakso, T., Miettinen, J., Oksman-Caldentey, K. M., & Oresic, M. (2008). Microbial metabolism of catechin stereoisomers by human faecal microbiota: comparison of targeted analysis and a non-targeted metabolomics method. Phytochemistry Letters, 1, 18–22.
6. Aura, A. M., O’Leary, K. A., Williamson, G., Ojala, M., Bailey, M., Puupponen-Pimia, R., et al. (2002). Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. Journal of Agriculture and Food Chemistry, 50, 1725–1730.
7. Bolca, S., Van de, W. T., & Possemiers, S. (2013). Gut metabotypes govern health effects of dietary polyphenols. Current Opinion in Biotechnology, 24, 220–225.
8. Calani, L., Dall’Asta, M., Derlindati, E., Scazzina, F., Bruni, R., & Del, R. D. (2012). Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins. Journal of Clinical Gastroenterology, 46(Suppl), S95–S99.
9. Chen, A. Y., & Chen, Y. C. (2013). A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry, 138, 2099–2107.
10. Chen, H., Hayek, S., Rivera, G. J., Gillitt, N. D., Ibrahim, S. A., Jobin, C., et al. (2012). The microbiota is essential for the generation of black tea theaflavins-derived metabolites. PLoS One, 7, e51001.
11. Chen, T. Y., Kritchevsky, J., Hargett, K., Feller, K., Klobusnik, R., Song, B. J., et al. (2015). Plasma bioavailability and regional brain distribution of polyphenols from apple/grape seed and bilberry extracts in a young swine model. Molecular Nutrition and Food Research, 59, 2432–2447.
12. Colten, H. R., Altevogt, B. M., & Institute of Medicine (and Committee on Sleep Medicine and Research). (2006). Sleep disorders and sleep deprivation an unmet public health problem. Institute of Medicine: Washington, DC.
13. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., et al. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.
14. Farzaei, M. H., Bahramsoltani, R., Rahimi, R., Abbasabadi, F., & Abdollahi, M. (2016). A systematic review of plant-derived natural compounds for anxiety disorders. Current Topics in Medicinal Chemistry, 16, 1924–1942.
15. Ferruzzi, M. G., Lobo, J. K., Janle, E. M., Cooper, B., Simon, J. E., Wu, Q. L., et al. (2009). Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease. Journal of Alzheimer’s Disease, 18, 113–124.
16. Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA, 262, 1479–1484.
17. Gasperotti, M., Passamonti, S., Tramer, F., Masuero, D., Guella, G., Mattivi, F., et al. (2015). Fate of microbial metabolites of dietary polyphenols in rats: Is the brain their target destination? ACS. Chemical Neuroscience, 6, 1341–1352.
18. Gillin, J. C. (1998). Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatrica Scandinavica. Supplementum, 393, 39–43.
19. Goel, N., Rao, H., Durmer, J. S., & Dinges, D. F. (2009). Neurocognitive consequences of sleep deprivation. Seminars in Neurology, 29, 320–339.
20. Hirotsu, C., Tufik, S., Bergamaschi, C. T., Tenorio, N. M., Araujo, P., & Andersen, M. L. (2010). Sleep pattern in an experimental model of chronic kidney disease. American Journal of Physiology—Renal Physiology, 299, F1379–F1388.
21. Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T. Y., et al. (2013). Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease. FASEB Journal, 27, 769–781.
22. Jiang, F., Chang, C. W., & Dusting, G. J. (2010). Cytoprotection by natural and synthetic polyphenols in the heart: novel mechanisms and perspectives. Current Pharmaceutical Design, 16, 4103–4112.
23. Kamphuis, J., Meerlo, P., Koolhaas, J. M., & Lancel, M. (2012). Poor sleep as a potential causal factor in aggression and violence. Sleep Medicine, 13, 327–334.
24. Kapur, V. K., Redline, S., Nieto, F. J., Young, T. B., Newman, A. B., & Henderson, J. A. (2002). The relationship between chronically disrupted sleep and healthcare use. Sleep, 25, 289–296.
25. Kiani, B. H., Suberu, J., & Mirza, B. (2016). Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin. Malar Journal, 15, 252.
26. Kimhi, S. (2016). Levels of resilience: Associations among individual, community, and national resilience. Journal of Health Psychology, 21, 164–170.
27. Kinrys, G., Coleman, E., & Rothstein, E. (2009). Natural remedies for anxiety disorders: potential use and clinical applications. Depression and Anxiety, 26, 259–265.
28. Knutson, K. L., & Van, C. E. (2008). Associations between sleep loss and increased risk of obesity and diabetes. Annals of the New York Academy of Sciences, 1129, 287–304.
29. Kreutzer, J. S., Marwitz, J. H., Sima, A. P., Bergquist, T. F., Johnson-Greene, D., Felix, E. R., et al. (2016). Resilience following traumatic brain injury: A traumatic brain injury model systems study. Archives of Physical Medicine and Rehabilitation, 97, 708–713.
30. Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., & Joseph, J. A. (2010). Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. British Journal of Nutrition, 103, 730–734.
31. Krishnan, V., & Nestler, E. J. (2008). The molecular neurobiology of depression. Nature, 455, 894–902.
32. Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22, 370–379.
33. Maes, M., Bosmans, E., De, J. R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine, 9, 853–858.
34. Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L., & Brzeszcz, J. (2011). Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinology Letters, 32, 7–24.
35. Maes, M., Van der, P. M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., et al. (1992). Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. Journal of Psychiatric Research, 26, 125–134.
36. Margalef, M., Pons, Z., Iglesias-Carres, L., Arola, L., Muguerza, B., & Arola-Arnal, A. (2016). Gender related similarities and differences in the body distribution of grape seed flavanols in rats. Molecular Nutrition and Food Research, 60, 760–772.
37. Milbury, P. E., & Kalt, W. (2010). Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. Journal of Agriculture and Food Chemistry, 58, 3950–3956.
38. Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.
39. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R., Garrido, I., Gomez-Cordoves, C., et al. (2010). Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food and Function, 1, 233–253.
40. Najafian, J., Mohamadifard, N., Siadat, Z. D., Sadri, G., & Rahmati, M. R. (2013). Association between sleep duration and diabetes mellitus: Isfahan Healthy Heart Program. Nigerian Journal of Clinical Practice, 16, 59–62.
41. Newman, D. J., & Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75, 311–335.
42. Ozdal, T., Sela, D. A., Xiao, J., Boyacioglu, D., Chen, F., & Capanoglu, E. (2016). The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients, 8(2), 78.
43. Palagini, L., Bruno, R. M., Gemignani, A., Baglioni, C., Ghiadoni, L., & Riemann, D. (2013). Sleep loss and hypertension: a systematic review. Current Pharmaceutical Design, 19, 2409–2419.
44. Pasinetti, G. M. (2012). Novel role of red wine-derived polyphenols in the prevention of Alzheimer’s disease dementia and brain pathology: Experimental approaches and clinical implications. Planta Medica, 78, 1614–1619.
45. Prasain, J. K., Peng, N., Dai, Y., Moore, R., Arabshahi, A., Wilson, L., et al. (2009). Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine, 16, 233–243.
46. Qureshi, N. A., & Al-Bedah, A. M. (2013). Mood disorders and complementary and alternative medicine: A literature review. Neuropsychiatric Disease and Treatment, 9, 639–658.
47. Rajaratnam, S. M. (2001). Legal issues in accidents caused by sleepiness. Journal of Human Ergology (Tokyo), 30, 107–111.
48. Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R., Debnam, E. S., Srai, S. K., et al. (2004). Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radical Biology and Medicine, 36, 212–225.
49. Rush, A. J., Warden, D., Wisniewski, S. R., Fava, M., Trivedi, M. H., Gaynes, B. N., et al. (2009). STAR*D: Revising conventional wisdom. CNS Drugs, 23, 627–647.
50. Russo, S. J., Murrough, J. W., Han, M. H., Charney, D. S., & Nestler, E. J. (2012). Neurobiology of resilience. Nature Neuroscience, 15, 1475–1484.
51. Schmidt, B., Ribnicky, D. M., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008). A natural history of botanical therapeutics. Metabolism, 57, S3–S9.
52. Selma, M. V., Espin, J. C., & Tomas-Barberan, F. A. (2009). Interaction between phenolics and gut microbiota: role in human health. Journal of Agriculture and Food Chemistry, 57, 6485–6501.
53. Spencer, J. P. (2009). The impact of flavonoids on memory: physiological and molecular considerations. Chemical Society Reviews, 38, 1152–1161.
54. Van Dongen, H. P., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003). The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep, 26, 117–126.
55. Vijayan, V. K. (2012). Morbidities associated with obstructive sleep apnea. Expert Review of Respiratory Medicine, 6, 557–566.
56. Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., & Chen, L. (2008). Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. Journal of Neuroscience, 28, 6388–6392.
57. Wang, D., Xia, M., Yan, X., Li, D., Wang, L., Xu, Y., et al. (2012a). Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circulation Research, 111, 967–981.
58. Wang, J., Ferruzzi, M. G., Ho, L., Blount, J., Janle, E. M., Gong, B., et al. (2012b). Brain-targeted proanthocyanidin metabolites for Alzheimer’s disease treatment. Journal of Neuroscience, 32, 5144–5150.
59. Wang, D., Ho, L., Faith, J., Ono, K., Janle, E. M., Lachcik, P. J., et al. (2015). Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease beta-amyloid oligomerization. Molecular Nutrition and Food Research, 59, 1025–1040.
60. Ward, N. C., Croft, K. D., Puddey, I. B., & Hodgson, J. M. (2004). Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. Journal of Agriculture and Food Chemistry, 52, 5545–5549.
61. Wollen, K. A. (2010). Alzheimer’s disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review, 15, 223–244.